Trademarkia Logo

Canada

C$
ERFANDEL
REGISTERED

on 13 Apr 2023

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

1837802 filed on 16th May 2017

Registration Number

TMA1176092 registered on 13th Apr 2023

Registration expiry Date

13th Apr 2033

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ERFANDEL

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases Read More

Classification Information


Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines


Classification kind code

11

Mark Details


Serial Number

1837802

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 3rd Aug 2020
Agent Changed
Submitted for opposition 110
on 29th Aug 2018
Proposed Opposition
Submitted for opposition 70
on 29th Aug 2018
Opposed
Submitted for opposition 42
on 27th Jun 2018
Advertised
Submitted for opposition 26
on 21st Jun 2018
Approved
Submitted for opposition 22
on 1st May 2018
Search Recorded
Submitted for opposition 27
on 1st May 2018
Approval Notice Sent
Submitted for opposition 31
on 19th May 2017
Formalized
Submitted for opposition 30
on 16th May 2017
Filed
Submitted for opposition 1
on 16th May 2017
Created